Advertisement

PGNY

Progyny, Inc.

Healthcare · USD

Set alert

Price alert · PGNY

All alert types
29.19 USD +0.79 +2.78%
As of Oct 30, 2026 Extended hours 29.19 0.00%
Bid
29.20 × 1
Ask
29.21 × 2
28.35 Day range 29.22
16.30 52-week range 32.36
YTD
+13.67%
1 year
+56.51%
Open
28.66
Prev close
28.40
Mkt cap
2.24B
Vol
807.73K
Avg vol
1.10M
EPS
0.92
P/E
31.73
Div yield
0.00%
More statistics
Low
28.35
High
29.22
Forward P/E
12.62
Beta
1.02
Short ratio
4.06
Inst. own
108.07%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
26.81
200-d avg
24.34
1y target
34.42

5D chart

Chart tools
Interval
PGNY five-day price chart27.628.028.428.829.3Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
2.24B
Enterprise value
1.97B
Trailing P/E
31.73
Forward P/E
12.62
PEG ratio
0.00
Price / sales
1.71
Price / book
4.94
EPS (TTM)
0.92
Beta
1.02
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
6.00%
Revenue (TTM)
1.31B
Revenue growth
5.30%
Free cash flow
196.47M
Total cash
236.92M
Total debt
26.97M
Return on equity
16.24%
Shares outstanding
76.73M
Short % of float
8.93%
50-day average
26.81
200-day average
24.34

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 34.42 +17.9% upside
Target (low)
30.00
Target (mean)
34.42
Target (high)
40.00
Ratings (0m) 12 10 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy9
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.50894.

Earnings history

Financials — quick view

All financials
PGNY Revenue — quarterly 350.51M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PGNY Net income — quarterly 28.05M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PGNY EPS — quarterly 0.36
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

PGNY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20260.313———
Aug 6, 2026Jun 30, 20260.33480.36+0.03+7.53%
May 7, 2026Mar 31, 20260.2560.30+0.04+17.19%
Feb 26, 2026Dec 31, 20250.1470.150.00+2.04%
Nov 6, 2025Sep 30, 20250.390.16-0.23-58.97%
Aug 7, 2025Jun 30, 20250.170.20+0.03+17.65%

Upgrades / downgrades

PGNY analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026Wells Fargoinit—Overweight
Sep 8, 2026CitizensmainMarket OutperformMarket Outperform
Aug 21, 2026JP MorganmainNeutralNeutral
Aug 20, 2026Wells Fargoinit—Overweight
Aug 13, 2026Truist SecuritiesmainBuyBuy
Aug 12, 2026BarclaysmainEqual-WeightEqual-Weight

About Progyny, Inc.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States
Website
progyny.com

News

Your note

Sign in to keep a note on PGNY — it syncs with the Stock Master app.

Insider holders

PGNY insider holders
InsiderRelationLatest transactionDateShares held
ANEVSKI PETERChief Executive OfficerStock Award(Grant)Mar 1, 2026816,834
CLAPP GEOFFREYOfficerConversion of Exercise of derivative securityJun 1, 202660,647
CUMMINGS MELISSA BChief Operating OfficerSaleJul 13, 202669,934
DEAN LLOYD HDirectorStock Award(Grant)May 20, 202626,519
HOLSTEIN ROGER CDirectorStock Award(Grant)May 20, 202628,729
LIVINGSTON MARK SChief Financial OfficerSaleJun 3, 202674,688

Institution ownership

PGNY institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.12%11,599,921338.60MJun 29, 2026
FMR, LLC9.13%7,004,280204.45MJun 29, 2026
Vanguard Portfolio Management LLC6.54%5,019,465146.52MJun 29, 2026
Vanguard Capital Management LLC4.18%3,210,72393.72MJun 29, 2026
State Street Corporation3.94%3,022,85988.24MJun 29, 2026
Ameriprise Financial, Inc.3.60%2,763,51480.67MJun 29, 2026

Fund ownership

PGNY fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%4,566,776133.30MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.92%2,242,82965.47MJun 29, 2026
Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com2.53%1,940,66656.65MJun 29, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF2.51%1,928,80756.30MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.48%1,902,27555.53MSep 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund2.18%1,676,01948.92MJul 30, 2026
Advertisement